Table 1. Characteristics of Subjectsa.
| Data | FD Group (N = 21) | SD Group (N = 21) |
|---|---|---|
| Age, y | 30.4 ± 6.7 | 28.4 ± 6.9 |
| Height, cm | 155 (150 - 160) | 155 (150 - 165) |
| IMT, kg/m 2 | 28.9 ± 4.2 | 27.3 ± 3.6 |
| Incision duration, min | 7.8 ± 2.2 | 8.9 ± 1.9 |
| Delivery duration, min | 14.6 ± 3.4 | 15.1 ± 3.1 |
| Surgery duration, min | 63 (44 - 93) | 63 (42 - 110) |
| Gestational age, wk | 38 (34 - 40) | 37 (34 - 41) |
| Birth weight, g | 2.600 (2.300 - 4.000) | 2.600 (2.300 - 3.700) |
| APGAR score 1st minute | 7 (4 - 8) | 7 (5 - 8) |
| APGAR score 5th minute | 8 (7 - 9) | 8 (7 - 9) |
| Hypertension comorbidity | ||
| Gestational hypertension | 5 (23.8) | 4 (19) |
| Preeclampsia | 1 (4.8) | 1 (4.8) |
| Severe preeclampsia | 15 (71.4) | 16 (76.2) |
| Hypertension/preeclampsia treatment | ||
| Nifedipine | 5 (23.8) | 4 (19) |
| MgSO4 and nifedipine | 16 (76.2) | 17 (81) |
| Spinal injection site | ||
| L3-L4 | 13 (61.9) | 9 (42.9) |
| L4-L5 | 8 (38.1) | 12 (57.1) |
| Amount of co-loading fluid, mL | 400 (300 - 600) | 450 (300 - 850) |
| Baseline MAP, mmHg | 107.5 ± 12 | 108.4 ± 13.7 |
a Values are expressed as mean ± SD or No. (%). If the distribution is not normal, data are presented in median (minimum - maximum).